Benzinga

64132.000.8989%

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Benzinga Edge
Benzinga Pro
Benzinga Research
Benzinga APIs
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Events Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

64132.000.8989%

Merck & Co Inc Stock News

MRKNYSE

Trade with Public

Trade with Public

$123.61

At close: Jul 16, 5:00 PM EST

$123.41

-0.20-0.16%

After Hours: 7:59 PM EST

PRO

Why Is It Moving?™:Merck shares are trading higher after the company announced the Phase 3 KE...

OverviewNewsEarnings Events Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Latest Merck & Co Stock News | NYSE:MRK | Benzinga

Get the latest news on Merck & Co stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Merck & Co performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, July 15, 2026

Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer
Vandana Singh
PRO
Merck shares are trading higher after the com...
Benzinga Newsdesk
PRO
Merck's Phase 3 KEYNOTE‑C93 Trial Evaluating ...
Benzinga Newsdesk

Monday, July 13, 2026

PRO
JP Morgan Maintains Overweight on Merck & Co,...
Benzinga Newsdesk
PRO
BMO Capital Maintains Outperform on Merck & C...
Benzinga Newsdesk
PRO
Guggenheim Maintains Buy on Merck & Co, Raise...
Benzinga Newsdesk
Why Merck Stock Is in the Spotlight Today
Dylan Berman

Friday, July 10, 2026

PRO
FDA Approves Pembrolizumab Or Pembrolizumab A...
Benzinga Newsdesk

Thursday, July 09, 2026

PRO
Morgan Stanley Maintains Equal-Weight on Merc...
Benzinga Newsdesk
Rick Scott Urges Trump to Increase Tariffs on Chinese Generic Drug Makers Over 'Uyghur Slave Labor' Claims
Snigdha Gairola

Wednesday, July 08, 2026

PRO
RBC Capital Reiterates Outperform on Merck & ...
Benzinga Newsdesk
Merck To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
PRO
Wells Fargo Maintains Overweight on Merck & C...
Benzinga Newsdesk

Monday, July 06, 2026

Generic Fears Overdone? Gilead Stock Has More Room to Run, Analyst Says
Vandana Singh
8 Health Care Stocks With Whale Alerts In Today’s Session
Benzinga Insights
PRO
Cantor Fitzgerald Reiterates Neutral on Merck...
Benzinga Newsdesk

Tuesday, June 30, 2026

PRO
B of A Securities Maintains Buy on Merck & Co...
Benzinga Newsdesk
PRO
Scotiabank Maintains Sector Outperform on Mer...
Benzinga Newsdesk
PRO
U.S. House Committee Sends Letters To Pfizer,...
Benzinga Newsdesk
Merck, AbbVie Hit With Congressional Probe Over China Drug Trials: Report
Vandana Singh
PRO
Reuters Reported AbbVie, Merck Face U.S. Hous...
Benzinga Newsdesk

Monday, June 29, 2026

PRO
Merck Agrees With ADAP Crisis Task Force To H...
Benzinga Newsdesk

Friday, June 26, 2026

PRO
CDC Raises Its Response Level To Congo Ebola ...
Benzinga Newsdesk
Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC’s ‘Final Trades’
Avi Kapoor

Thursday, June 25, 2026

PRO
CNBC Halftime Report Final Trades: Qualcomm, ...
Benzinga Newsdesk
Gilead's Trodelvy Expands Reach With New FDA Approval In Breast Cancer
Vandana Singh
PRO
Merck Announces FDA Approval Of KEYTRUDA And ...
Benzinga Newsdesk

Wednesday, June 24, 2026

PRO
The European Union Approves Merck's Keytruda ...
Benzinga Newsdesk

Monday, June 22, 2026

Merck Scores Key Phase 3 Win For Novel Ulcerative Colitis Therapy
Vandana Singh
PRO
Phase 3 ATLAS-UC induction-Only Study Met Pri...
Benzinga Newsdesk
Merck Reports Topline Results From Phase 3 ATLAS-UC Induction-Only Study Evaluating Tulisokibart
Benzinga News-desk
PRO
Merk Announces Topline Results From Its Phase...
Benzinga Newsdesk

Thursday, June 18, 2026

FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens
Vandana Singh
PRO
Merck Announces FDA Approval Of An Expanded I...
Benzinga Newsdesk

Tuesday, June 16, 2026

PRO
Protillion Biosciences Signs Discovery Collab...
Benzinga Newsdesk

Friday, June 12, 2026

PRO
Merck's Belzutifan In Combination With Pembro...
Benzinga Newsdesk

Thursday, June 11, 2026

PRO
Merck To Acquire TARGAN, A Maker Of Poultry B...
Benzinga Newsdesk

Tuesday, June 09, 2026

Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial
Vandana Singh
PRO
Merck Exec Says "We Have Every Indication Tha...
Benzinga Newsdesk
PRO
Merck CEO Says Co Will Focus On $1 Billion To...
Benzinga Newsdesk
7 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights

Monday, June 08, 2026

PRO
Gilead And Merck Report Phase 3 Results For O...
Benzinga Newsdesk
PRO
Merck And Gilead Discontinue Phase 3 KEYNOTE-...
Benzinga Newsdesk

Thursday, June 04, 2026

PRO
Shares of pharmaceutical companies are tradin...
Benzinga Newsdesk
PRO
'Merck to Settle Bulk of Gardasil Lawsuits fo...
Benzinga Newsdesk

Monday, June 01, 2026

Moderna Reports Strong 5-Year Cancer Vaccine Data, Expands CEPI Partnership; Stock Falls
Vandana Singh
PRO
Moderna And Merck Present 5-Year Data For Int...
Benzinga Newsdesk

Friday, May 29, 2026

PRO
Merck Announces FDA Breakthrough Therapy Desi...
Benzinga Newsdesk

Friday, May 22, 2026

Dow Jones Hits Record Highs, DELL Jumps 15%: Stock Market Today
Piero Cingari
PRO
European Medicines Agency's Committee For Med...
Benzinga Newsdesk

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved